DiJoseph, JF, K Khandke, MM Dougher, DY Evans, DC Armellino, PR Hamann, and NK Damle. “CMC-544 (inotuzumab ozogamicin): A CD22-Targeted Immunoconjugate of Calicheamicin”. Hematology Meeting Reports (formerly Haematologica Reports) 2, no. 5 (June 23, 2009). Accessed November 22, 2024. https://www.pagepress.org/journals/hmr/article/view/735.